Skip to content

Automated speech analysis in psychosis

Automated speech analysis in psychosis - SPEECH

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON51301
Enrollment
200
Registered
2023-01-07
Start date
2022-07-01
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psychosis schizophrenia psychosis

Interventions

None listed

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
16 Years to 64 Years

Inclusion criteria

Inclusion criteria: 1. All participants must give signed informed consent; 2. Participants have a psychotic disorder classified according to DSM-5; 3. Participants are 16-46 years

Exclusion criteria

Exclusion criteria: 1. Unable to give informed consent to all aspects of the study; 2. Unable to speak and be interviewed in Dutch; 3. Neurological comorbidities affecting speech, e.g. brain haemorrhage.

Design outcomes

Primary

MeasureTime frame
Automatic quantified acoustic aspects of speech (e.g duration of pauses, changes in pitch and mean sentence lengths) and complex tests scores at the different linguistic levels phonology, semantics and syntax selected for language production and comprehension.

Secondary

MeasureTime frame
We will relate speech characteristics and test scores from the DIMA to the severity of positive, negative and cognitive psychosis symptoms. We will also quantify the movement assessments and exploratorily related these measures to PANSS scores (and possibly to speech characteristics).

Countries

Netherlands

Contacts

Public ContactN.H. Grootendorst

Erasmus MC, Universitair Medisch Centrum Rotterdam

n.grootendorst@erasmusmc.nl0650008256

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: May 1, 2026